Smoking does not impact social and non-social cognition in patients with first episode psychosis
Autor:
Sánchez-Gutiérrez, Teresa
; García-Portilla, M. Paz
; Parellada, Mara
; Bobes, Julio
; Calvo, Ana
; Moreno-Izco, Lucía
; ...et al.
; Balanza, Vicent
Fecha:
09/2018Palabra clave:
Revista / editorial:
Schizophrenia ResearchTipo de Ítem:
Articulo Revista IndexadaResumen:
Background: Many studies having shown significant improvements in non-social and social cognitive performance in smoking FEP patients compared to non-smoking FEP patients. The findings are controversial. This study analyzed the effects of tobacco use on non-social and social cognitive function in a large group of FEP patients and a matched healthy control group.
Methods: A sample of 335 patients with FEP and 253 healthy controls was divided into four subgroups: control tobacco users (CTU), control non-tobacco users (CNTU), patient tobacco users (PTU) and patient non-tobacco users (PNTU). Demographic variables, tobacco use variables (presence or absence, frequency and duration of tobacco use), neurocognitive (non-social) performance and social cognition were assessed.
Results: Comparison of 4 subgroups in non-social cognitive function revealed significant differences after controlling for covariables in executive functions (F = 13.45; p <= 0.001) and working memory domains (F = 4.30; p = 0.005). CTU and CNTU subgroups scored higher in all the domains compared to the PTU and the PNTU subgroups respectively. Social cognitive function was also significantly different within the four subgroups, with control subgroups showing better social cognition than patient subgroups. Significant differences in the executive functions domain were observed when comparing PTU and CTU groups (F = 19.60; p = 0.001). No significant differences were revealed in the comparison between the patient groups.
Conclusions: This large study suggests that tobacco use in FEP patients is not related to better non-social or social cognitive performance.
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
115 |
56 |
31 |
45 |
49 |
96 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Tobacco use in first-episode psychosis, a multinational EU-GEI study
Sanchez-Gutierrez, Teresa; Rodriguez-Toscano, E.; Ferraro, Laura; Parellada, Mara; Calvo, Ana; Roldan, Laura; López, G.; Rapado-Castro, Marta; La Barbera, Daniele; La Cascia, Caterina; Tripoli, Giada; Di Forti, Marta; Murray, Robin M.; Quattrone, Diego; Morgan, Craig; Van Os, Jim; Garcia-Portilla, P.; Al-Halabi, S.; Bobes, Julio; de Haan, Lieuwe; Bernardo, Miguel; Santos, Jose Luis; Sanjuán, Julio; Arrojo, Manuel; Ferchiou, A.; Szöke, Andrei; Rutten, Bart P.; Stilo, S.; D'Andrea, G.; Tarricone, Ilaria; Diaz-Caneja, C. M.; Arango, Celso (Psychological Medicine, 2023)BackgroundTobacco is a highly prevalent substance of abuse in patients with psychosis. Previous studies have reported an association between tobacco use and schizophrenia. The aim of this study was to analyze the relationship ... -
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Rodríguez-Toscano, Elisa; Alloza, Clara; Fraguas, David; Durán-Cutilla, Manuel; Roldán, Laura; Sánchez-Gutiérrez, Teresa; López-Montoya, Gonzalo; Parellada, Mara; Moreno, Carmen; Gayer-Anderson, Charlotte; E Jongsma, Hannah; Di Forti, Marta; Quattrone, Diego; Velthorst, Eva; de Haan, Lieuwe; Selten, Jean-Paul; Szöke, Andrei; Llorca, Pierre-Michel; Tortelli, Andrea; Bobes, Julio; Bernardo, Miguel; Sanjuán, Julio; Santos, José Luis; Arrojo, Manuel; Tarricone, Ilaria; Berardi, Domenico; Ruggeri, Mirella; Lasalvia, Antonio; Ferraro, Laura; La Cascia, Caterina; La Barbera, Daniele; Rossi Menezes, Paulo; Del-Ben, Cristina Marta; EU-GEI WP2 Group; Rutten, Bart P.; van Os, Jim; Jones, Peter B.; M. Murray, Robin; B. Kirkbride, James; Morgan, Craig; Díaz-Caneja, Covadonga M.; Arango, Celso (Schizophrenia Bulletin, 2023)Background: Use of illegal stimulants is associated with an increased risk of psychotic disorder. However, the impact of stimulant use on odds of first-episode psychosis (FEP) remains unclear. Here, we aimed to describe ... -
The relationship of symptom dimensions with premorbid adjustment and cognitive characteristics at first episode psychosis: Findings from the EU-GEI study
Ferraro, Laura; La Cascia, Caterina; La Barbera, Daniele; Sánchez-Gutiérrez, Teresa ; Tripoli, Giada; Seminerio, Fabio; Sartorio, Crocettarachele; Sideli, Lucia; Arango, Celso; Arrojo, Manuel; Bernardo, Miguel; Bobes, Julio; Del-Ben, Cristina Marta; Gayer-Anderson, Charlotte; Jongsma, Hannah E.; Kirkbride, James B.; Lasalvia, Antonio; Tosato, Sarah; Llorca, Pierre-Michel; Menezes, Paulo Rossi; Rutten, Bart P.; Santos, Jose Luis; Sanjuán, Julio; Selten, Jean-Paul; Szöke, Andrei; Tarricone, Ilaria; Muratori, Roberto; Tortelli, Andrea; Velthorst, Eva; Rodriguez, Victoria; Quattrone, Andrea; Jones, Peter B.; Van Os, Jim; Vassos, Evangelos; Morgan, Craig; de Haan, Lieuwe; Reininghaus, Ulrich; Cardno, Alastair G.; Di Forti, Marta; Murray, Robin M.; Quattrone, Diego (Elsevier B.V., 2021)Premorbid functioning and cognitive measures may reflect gradients of developmental impairment across diagnostic categories in psychosis. In this study, we sought to examine the associations of current cognition and premorbid ...